510(k) Report

510(k) · Cleared

Cleared

Quickvue Advance PH and Amines GLL Test

K040008510(k) TraditionalCleared Apr 29, 2004118-day reviewClass I21 CFR 862.1550

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Quidel Corp. · CEN Dye-Indicator, Ph (Urinary, Non-Quantitative)

Cleared on Apr 29, 2004 as substantially equivalent to K962718 (Litmus Concepts, Inc., 1997) after a 118-day review. Its family tree reaches back 1 generation to 1997.

Decided
Apr 29, 2004
Review
118 days
Class
Class I
Product code
CEN
Recalls
None
Predicates
1

Its longest line of descent runs back 1 generation to K962718 (1997). No later device cites it as a predicate yet.

K962718 · Femexam Testcard · Litmus Concepts, Inc. · 1997199619982000200220042006
K962718 · Femexam Testcard · Litmus Concepts, Inc. · 19970
  1. Root · 1 generation backK962718 Femexam TestcardLitmus Concepts, Inc. · 1997
  2. This deviceK040008 Quickvue Advance PH and Amines GLL TestQuidel Corp. · 2004
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−1K962718Femexam TestcardLitmus Concepts, Inc.1997—
0 (this device)K040008Quickvue Advance PH and Amines GLL TestQuidel Corp.2004—
FIG. 1 — Lineage of K040008, 1997–2004Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in CEN? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

  • Candidate predicates for a device like this, rankedin the report
  • Recall history across each candidate’s familyin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K962718Femexam Testcard
Summary page 2
…emonstrated the substantial equivalence of the QuickVue Advance pH and Amines gll test to existing products already marketed, including the FemExam TestCard test [510(k) K962718], also sold under the brand name QuickVue Advance pH and Amines test. They further demonstrated the suitability of the product fo…
Litmus Concepts, Inc.1997—

Also cleared against K962718: 1 other device →

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Its one ancestor has no recall.
  • 1 other device also cites its predicate K962718.

How does its category compare?

All CEN devices

CEN Dye-Indicator, Ph (Urinary, Non-Quantitative): FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · CEN

1in 2009

2007: 12009: 1
2007high 1 (2007) · low 0 (2008)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · CEN

Too few CEN 510(k)s in any year since 2007 to give a median.

Recalls per year · CEN

2in 2025

2023: 12025: 22026 (partial year): 1
2007high 2 (2025) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · CEN

1in 2018

2012: 32018: 1
2007high 3 (2012) · low 0 (2007)2025

MAUDE reports naming product code CEN, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20071—00
20080—00
20091—00
20100—00
20110—00
20120—03
20130—00
20140—00
20150—00
20160—00
20170—00
20180—01
20190—00
20200—00
20210—00
20220—00
20230—10
20240—00
20250—20
20260—1—

What is it indicated for?

The QuickVue Advance pH and Amines gil test contains two calorimetric tests intended for the qualitative detection of elevated vaginal fluid pH (pH > 4.7) and the presence of volatile vaginal fluid amines. The test is intended for use by health care professionals as an aid in the diagnosis of bacterial vaginosis.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K040008: Quickvue Advance PH and Amines GLL Test.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K040008

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026